New Drugs Seagen Announces FDA Accelerated Approval of Tukysa (tucatinib) in Combination with Trastuzumab for People with Previously Treated RAS Wild-Type, HER2-Positive Metastatic Colorectal Cancer 2 years ago
Pharma Industry News January 19 2023 – Sun Pharma to purchase Concert Pharmaceuticals for $576M 2 years ago